HIAL
GMAB icon

Highland Investment Advisors LLC’s Genmab GMAB Stock Holding History

Highland Investment Advisors LLC’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275 Buy
+10
New +$266 ﹤0.01% 608

Other funds holding GMAB

Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Highland Investment Advisors LLC's GMAB Position: Q2 2026 in Review

Highland Investment Advisors LLC opened a new position in Genmab (GMAB) in Q2 2026: 10 shares worth $275. The stake represents ﹤0.01% of the portfolio and ranks #608 among its holdings.

216 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Highland Investment Advisors LLC held 10 shares of Genmab worth $275 as of Q2 2026.
  • Genmab was a new Highland Investment Advisors LLC position in Q2 2026.
  • Genmab made up ﹤0.01% of Highland Investment Advisors LLC's portfolio in Q2 2026, its #608 holding.
  • 216 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Highland Investment Advisors LLC's 13F filing for Q2 2026, filed 13 Aug 2026.